Zygomycosis in neutropenic patients with past Aspergillus infection: a role for posaconazole?
| Autor: | H. Demuynck, R. De Man, I. Buysschaert, E. De Laere, Louis Ide, Annemie Verlinde, Ignace Surmont |
|---|---|
| Rok vydání: | 2004 |
| Předmět: |
Microbiology (medical)
Aspergillus Posaconazole biology business.industry General Medicine Bacitracin biochemical phenomena metabolism and nutrition Neutropenia Aspergillosis medicine.disease biology.organism_classification Microbiology Infectious Diseases Antibiotic resistance medicine Zygomycosis business medicine.drug Enterococcus faecium |
| Zdroj: | Clinical Microbiology and Infection. 10:862-863 |
| ISSN: | 1198-743X |
| Popis: | Recommendation for preventing the spread of vancomycin resistance. Infect Control Hosp Epidemiol 1995; 16: 105–113. 5. Chia JKS, Nakata MM, Park SS, Lewis RP, McKee B. Use of bacitracin therapy for infection due to vancomycin-resistant Enterococcus faecium. Clin Infect Dis 1995; 21: 1520. 6. Whitman MS, Pitsakis PG, DeJesus E, Osborne AJ, Levison ME, Johnson CC. Gastrointestinal tract colonisation with vancomycin-resistant Enterococcus faecium in an animal model. Antimicrob Agents Chemother 1996; 40: 1526–1530. 7. Anonymous. European Antimicrobial Resistance Surveillance System Newsletter. Bilthoven, The Netherlands: National Institute of Public Health and the Environment, 2002. 8. Bonten JM, Willems R, Weinstein RA. Vancomycin-resistant enterococci: why are they here, and where do they come from? Lancet Infect Dis 2001; 1: 314–325. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|